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Abstract Post-stroke depression (PSD) and post-stroke
fatigue (PSF) are frequent and persistent problems among
stroke survivors. Therefore, awareness of signs and
symptoms of PSD and PSF is important for their treatment
and recovery from stroke. Additionally, since sudden
serious illness can result in disequilibrium, early institution
of a coping process is essential to restoring stability. The
brain damage of stroke leaves patients with unique physical
and mental dysfunctions for which coping maybe a key
resource while rebuilding lives. We evaluated 368 con-
secutive patients with acute ischemic stroke for post-stroke
emotional disorders at admission and 3 months later. PSD
was evaluated by using the Beck Depression Inventory, and
PSF was scored with the Fatigue Severity Scale. The Social
Support Rating Scale and Medical Coping Modes Ques-
tionnaire were also used as measurement tools. Locations
of lesions were based on MRI. Those scans revealed
infarcts located in the basal ganglia, corona radiate and
internal capsule and constituted the independent factors
associated with PSF 3 months after stroke occurrence.
Conversely, PSD was not related to lesion location.
Acceptance-resignation related to PSD and PSF both at
admission and 3 months after stroke. Avoidance was the
independent factor most closely related to PSD, whereas
confrontation was the independent factor best related to
PSF at 3 months after stroke onset.
Keywords Post-stroke depression  Post-stroke fatigue 
Coping styles  Lesion location
Introduction
Each year, of the approximately 15 million human stroke
victims worldwide, at least five million die, and one-third
remain disabled [1]. Overwhelming feelings of fatigue, that
is, tiredness and lack of energy, is the chief complaint in
more than half of the 10 million survivors [2]. Fatigue as a
common post-stroke emotional disturbance always impairs
patients’ ability to regain lost functions [3] and leads to
negative long-term outcomes. Similarly, post-stroke
depression (PSD) mainly manifested as sadness, reduction
of interest and pleasure, and multiple psychological and
vegetative symptoms [4] afflicts 20–65 % of these patients,
depending on the population studied, the assessment
measures, and the definition of depression applied [5]. As
the most common psychological sequel of stroke, patients
who had PSD experienced the least benefit from rehabili-
tation, the poorest quality of life and a substantially
increased risk of suicide [6].
Several cross-sectional papers have linked fatigue with
depression after stroke [7]. In a Swedish study, 49 % of
patients with fatigue 1 year after stroke were diagnosed
with depression compared with 39 % in the total sample
[8]. Similarly, in a Korean study, 34 % of patients diag-
nosed as depressed were among those with fatigue
approximately 15 months after stroke [7]. Fatigue was
considered an essential component of PSD [9], and
depression-related symptoms such as insomnia or appetite
loss resulted in fatigue [10]. In contrast, PSF accompanying
PSD is often relieved when the depression is adequately
treated [11]. An association between these two syndromes
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at a particular time point does not necessarily mean that
one causes the other or exclude the possibility that a third
factor causes both. Nevertheless, among all these attempts
to make sense of PSD and PSF, identifying predictors and
early signs is crucial for taking preventive measures, pro-
moting early diagnosis, implementing early and adequate
treatment, and improving quality of life, both for patients
with stroke and for their caregivers.
Some studies invoke more physiologic than behavioral
causes for PSD and PSF by suggesting that the extent of
stroke-induced functional residual impairment is the major
risk factor. Others suggest a possible biological relation-
ship between the occurrence of emotional disturbances and
structural brain damage [5]. However, the effect of lesion
location has remained the most controversial purported
cause of PSD and PSF. With, social support and coping
styles also prominent considerations. Coping refers to the
person’s cognitive and behavioral efforts to manage (re-
duce, minimize, master, or tolerate) the internal and
external demands of his/her environment that seem too
taxing or exceed personal resources [12]. Moos and Tsu
[13] proposed that sudden serious illness often results in
disequilibrium, which triggers adaptive processes to restore
equilibrium. The coping process, initiated to restore equi-
librium (adaptation), includes cognitive appraisal of the
illness, identification of adaptive tasks and coping skills.
Contextual factors (background, patient illness and social–
environmental variables) shape these coping factors.
Emotional disturbance and physical health are designated
as adaptation outcomes. Since stroke is considered a spe-
cial physical illness with neurological dysfunction and
brain damage, coping may be the key psychological
resource involved in rebuilding the lives of patients.
Studies assessing coping strategies in patients after stroke
have produced inconsistent results [14]. In this context, we
evaluated PSD and PSF at different stages after cerebral
infarction and attempted to correlate patients’ symptoms
with lesion location, coping styles and other variables. The
goal of this research is to provide new insight into the
rehabilitation and management of stroke.
Subjects and methods
Participants
This descriptive, cohort study was conducted with stroke
patients upon admission and at 3 months afterward. Our
study was approved by the ethics committees of Tianjin
Medical University General Hospital. All participants
provided written informed consent. We evaluated 989
consecutive patients who were admitted to Tianjin Medical
University General Hospital (Tianjin, China) with a
diagnosis of acute stroke, between Jan 2012 and Jun 2014.
The diagnosis was confirmed based on CT or MRI findings
within 7 days after stroke onset. Exclusion criteria applied
to patients with hemorrhagic stroke (n = 83); those with
unusual causes such as dissection, venous infarction, or
moyamoya disease (n = 77); those with transient ischemic
attack without progression to stroke (n = 120); those with
communication problems (decreased consciousness, con-
fusion, aphasia, dementia, or dysarthria) severe enough to
preclude a reliable interview (n = 142); and those with
very severe neurologic or medical conditions (such as
metastatic cancer) (n = 54). We also excluded patients
who scored B23 on the Mini-Mental State Examination
(n = 31), patients diagnosed with depression or other
psychiatric illnesses or treated with selective serotonin
reuptake inhibitors before the onset of stroke (n = 16),
patients who lived alone (because no information was
available from relatives) (n = 9), patients who did not
undergo a complete follow-up (n = 37), and patients who
did not sign an informed consent (n = 52). Finally, 368
patients were enrolled into the study.
Before the project began officially, all interviewers/
raters completed and passed a consistency-training exam-
ination. Two researchers (L.C. and F. Z.) recorded all
clinical and socio-demographic information. The neu-
ropsychological evaluations were recorded by one of the
authors (C. W.) and supervised by a psychiatrist (L. L.). An
experienced stroke neurologist (N. Z.) documented
patients’ neurologic findings during the 3-month follow-up,
and one of the authors with experience in neuroimaging (F.
Z.) analyzed MRI and Fazeka’s scale scores. Questions
arising during subsequent interviews were brought to a
research team meeting for group consensus on the appro-
priate answer.
Testing instruments
Depression was assessed with the Beck Depression
Inventory (BDI) [15], which was self-recorded. Fatigue
was measured on the fatigue severity scale [16, 17]. To
calculate cognitive functioning we applied the Mini-Mental
State Examination (MMSE) [18], a measure of global
cognitive decline that encompasses basic cognitive
domains. The Social Support Rating Scale (SSRS) [19] was
adopted to evaluate social support, which consisted of three
dimensions: objective support, subjective support and the
degree of social utilization. Coping styles were measured
with the Medical Coping Modes Questionnaire (MCMQ)
[20, 21], which is a 19-item instrument that addresses three
forms of coping: confrontation, avoidance and acceptance-
resignation.
MRI studies were performed on a 3.0T clinical scanner
(HDx, General Electric, USA) with an 8-channel phase-
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array coil. Locations of lesions based on MRI were char-
acterized as anterior cortical when identified in the anterior
cerebral artery territory, the frontal and parietal areas of the
middle cerebral artery, or predominantly in the temporal
lobe of the middle cerebral artery territory. Posterior cor-
tical referred to the lesions at the following occipital area
or medial temporal area of the posterior cerebral artery
territory; internal capsule/corona radiata/basal ganglia of
the lenticulostriate artery territory; thalamus; pons,
including pure midbrain lesions; medulla; and cerebellum
[19]. White matter intensity (leukoaraiosis) derived from
fluid-attenuated inversion recovery (FLAIR) imaging was
graded from 0 to 3 on Fazeka’s scale of deep white matter
changes, with scores of 2 and 3 indicating significant
leukoaraiosis [20].
Procedure
Each first interview was completed at approximately
14 days after the onset of stroke to ensure that the patients
were stable. We tried our best to avoid conducting the
interviews under conditions of acute neurologic progres-
sion or any other condition that could affect the emotions
of patients or assessments made by our team. To ensure
that each evaluation was reliable, patients were asked to
take the interview accompanied by the caregiver who lived
with him/her. The caregiver was present to verify the
information and to assist the patient, but could not take part
in the assessment. Neurologic and psychological assess-
ments (including BDI, FSS, SSRS, MCMQ, Fazeka’s scale
and symptom observation) were completed by doctors
assigned specifically for that purpose. MMSE was used for
cognition screening, excluding dementia. The second
patient interview was performed 3 months after the onset
of stroke. Neurologic and psychological assessments were
completed by the same doctors who conducted the first
interview.
Diagnostic criteria
PSD was diagnosed in patients with a BDI score[13 or
those who met the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV) [22, 23]. The presence of PSF
is defined as an FSS score of 4.0 or more, because fewer
than 5 % of healthy controls rate their fatigue at that level.
However, 60–90 % of patients with medical disorders
experience fatigue at or above that score [3].
Statistical analyses
Ages, years of education, MCMQ and SSRS scores were
compared using Mann–Whitney U tests, because they were
not normally distributed. Variables of frequency were
compared using Chi-square tests. Fisher’s exact probability
test was used in tests of dichotomous variables when small
numbers were involved. Multiple logistic regression anal-
ysis was used to explore relationships among PSF/PSD
variables. The level of significance was set at P\ 0.05. All
data were analyzed by SPSS version 19.0 (IBM Corp.,
Armonk, NY).
Results
Prevalence of PSD and PSF
A total of 368 participants was enrolled within 14 days
after the onset of stroke and completed their second
interview at 3 months after the stroke. PSD was diagnosed
in 19.3 % of the patients at admission and in 23.6 % at
3 months. Of the 71 patients who developed PSD during
the acute stage of stroke, 23 recovered but 48 still had PSD
after 3 months. In comparison, 39 patients without PSD at
admission had developed PSD at 3 months. PSF was pre-
sent in 23.4 % of the patients at admission and in 29.6 % at
3 months. Of the 86 patients who developed PSF during
the acute stage of stroke, 28 recovered and 58 still had PSF
at 3 months, whereas 51 patients without PSF at admission
developed PSF at 3 months. Further, 75.6 % (65/86) of the
patients who had PSF at admission presented with PSD
3 months after stroke. More than half (38/71, 53.5 %) of
the patients who had PSD at admission presented with PSF
3 months after stroke. In addition, 10.9 % (40/368) and
12.2 % (45/368) of the patients had PSD accompanied by
PSF at admission and 3 months later, respectively.
Factors related to PSD and PSF
Both motor and sensory dysfunction at admission
(P\ 0.01) compared with only motor or only sensory
dysfunction was related to PSD at admission. Patients who
prefer acceptance-resignation (MCMQ; P\ 0.01) were
prone to PSD at admission. Three months later, none of the
above risk factors for PSD changed significantly. More-
over, the patients who manifested a lower degree of social
utilization (SSRS; P\ 0.05) and chose avoidance coping
styles (MCMQ; P\ 0.01) were more prone to PSD. We
also found that the patients who had only sensory dys-
function at admission (P\ 0.05) were not susceptible to
PSD (Table 1).
Patients with both motor and sensory dysfunction
(P\ 0.01) were more susceptible to PSF at admission
compared to individuals with motor or only sensory dys-
function (P\ 0.01). Moreover, acceptance-resignation
(MCMQ; P\ 0.01) styles, low objective support (SSRS;
P\ 0.05) and degree of social utilization (SSRS;
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P\ 0.05) were also predictive factors for PSF. Basal
ganglia (BG), corona radiate (CR) or internal capsule (IC)
infarction (P\ 0.05), low degree of social utilization
(SSRS; P\ 0.01), confrontation (MCMQ; P\ 0.05), and
acceptance-resignation (MCMQ; P\ 0.01) were all sig-
nificant risk factors associated with PSF at 3 months
Table 1 Factors associated with PSD at admission and 3 months later
Variable Admission 3 months after stroke
Present (n = 71) Absent (n = 297) Present (n = 87) Absent (n = 281)
Age (y), mean ± SD 61.3 ± 9.4 61.6 ± 9.8 62.0 ± 9.7 60.0 ± 9.6
Female, n (%) 21 (29.6) 86 (29.0) 29 (33.3) 78 (27.8)
Education (y), mean ± SD 10.7 ± 3.5 10.8 ± 3.4 11.0 ± 3.7 10.7 ± 3.3
Previous stroke, n (%) 33 (46.5) 147 (49.5) 38 (43.7) 142 (50.5)
Weekly working time, n (%)
0 h 52 (73.2) 164 (55.2) 56 (64.4) 160 (56.9)
1–20 h 1 (1.4) 10 (3.4) 1 (1.1) 10 (35.6)
21–30 h 2 (2.8) 20 (6.7) 2 (2.3) 20 (7.1)
31–40 h 7 (9.9) 64 (21.5) 15 (17.2) 56 (19.9)
41–50 h 5 (7.0) 23 (7.7) 6 (6.9) 22 (7.8)
51–60 h 3 (4.2) 9 (3.0) 5 (5.7) 7 (2.5)
[60 h 1 (1.4) 7 (2.4) 2 (2.3) 6 (2.1)
Lesion location, n (%)
Anterior cortex 15 (21.1) 71 (23.9) 24 (27.6) 62 (22.1)
CR ? BG ? IC 18 (25.3) 92 (31.0) 25 (28.7) 85 (30.2)
Thalamus 5 (7.0) 35 (11.8) 8 (9.2) 32 (11.4)
Pons ? midbrain 20 (28.2) 42 (14.1) 18 (20.7) 44 (15.7)
Medulla 1 (1.4) 8 (2.7) 1 (1.1) 8 (2.8)
Cerebellum 4 (5.6) 17 (5.7) 4 (4.6) 17 (6.0)
Posterior cortex 8 (11.3) 32 (10.8) 7 (8.0) 33 (11.7)
Laterality, n (%)
Left 33 (46.5) 133 (44.8) 40 (46.0) 126 (44.8)
Right 24 (33.8) 128 (43.1) 33 (37.9) 119 (42.3)
Bilateral 14 (19.7) 36 (12.1) 14 (16.1) 36 (12.8)
White matter change, n (%)
Severe 41 (57.7) 144 (48.5) 44 (50.6) 141 (50.2)
Mild 30 (42.3) 153 (51.5) 43 (23.8) 140 (49.8)
Dysfunction at admission, n (%)
Motor dysfunction 35 (49.3) 165 (55.6) 45 (51.7) 155 (55.2)
Sensory dysfunction 7 (9.9) 49 (16.5) 6 (6.9) 50 (17.8)*
Both motor and sensory dysfunction 25 (35.2) 46 (15.5)** 33 (37.9) 38 (13.5)**
MCMQ, mean ± SD
Confrontation 20.4 ± 2.5 20.1 ± 2.5 20.4 ± 2.8 20.1 ± 2.4
Avoidance 14.5 ± 1.6 14.2 ± 1.5 14.9 ± 1.8 14.1 ± 1.4**
Acceptance-resignation 9.5 ± 2.0 7.9 ± 1.8** 10.3 ± 1.7 7.6 ± 1.6**
SSRS, mean ± SD
Subjective support 23.6 ± 2.2 23.8 ± 2.1 23.6 ± 2.2 23.8 ± 2.1
Objective support 9.9 ± 0.9 9.7 ± 1.0 9.8 ± 1.1 9.7 ± 0.9
Degree of social utilization 6.0 ± 1.0 6.0 ± 1.0 5.8 ± 0.9 6.1 ± 1.1*
BG basal ganglia, CR corona radiata, IC internal capsule, MCMQ Medical Coping Modes Questionnaire, n number, PSD post-stroke depression,
SSRS Social Support Rating Scale, y years
* P B 0.05
** P B 0.01
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(Table 2). We also found that patients with 1–20 h weekly
working time and cerebellum infarction were not suscep-
tible to PSF (P\ 0.05; Table 2).
As presented in tabular form (Table 3), multivariate
logistic regression analysis indicated that initial presenta-
tion with PSD at admission was related to both motor and
Table 2 Factors associated with PSF at admission and 3 months later
Variable Admission 3 months after stroke
Present (n = 86) Absent (n = 282) Present (n = 109) Absent (n = 259)
Age (y), mean ± SD 61.8 ± 9.5 60.5 ± 10.1 61.7 ± 9.2 61.5 ± 9.8
Female, n (%) 22 (25.6) 85 (30.1) 26 (23.9) 81 (31.3)
Education (y), mean ± SD 10.7 ± 3.7 10.8 ± 3.4 10.7 ± 3.4 10.8 ± 3.4
Previous stroke, n (%) 40 (46.5) 140 (49.6) 54 (49.5) 126 (48.6)
Weekly working hours, n (%)
0 h 54 (62.8) 162 (57.4) 62 (56.9) 154 (59.5)
1–20 h 0 (0.0) 11 (3.9) 0 (0.0) 11 (4.2)*
21–30 h 4 (4.7) 18 (6.4) 5 (4.6) 17 (6.6)
31–40 h 14 (16.3) 57 (20.2) 21 (19.3) 50 (19.3)
41–50 h 8 (9.3) 20 (7.1) 11 (10.1) 17 (6.6)
51–60 h 4(4.7) 8(2.8) 8(7.3) 4(15.4)
More than 60 h 2 (2.3) 6 (2.1) 2 (1.8) 6 (2.3)
Lesion location, n (%)
Anterior cortex 19 (22.1) 67 (23.8) 22 (20.2) 64 (24.7)
CR ? BG ? IC 29 (33.7) 81 (28.7) 42 (38.5) 68 (26.3)*
Thalamus 9 (10.5) 31 (11.0) 12 (11.0) 28 (10.8)
Pons ? midbrain 19 (22.1) 43 (15.2) 20 (18.3) 42 (16.2)
Medulla 1 (1.2) 8 (2.8) 4 (3.7) 5 (1.9)
Cerebellum 3 (3.5) 18 (6.4) 2 (1.8) 19 (7.3)*
Posterior cortex 6 (7.0) 34 (12.1) 7 (6.4) 33 (12.7)
Laterality, n (%)
Left 38 (32.6) 128 (45.4) 47 (43.1) 119 (45.9)
Right 35 (40.7) 117(41.5) 48(44.0) 104(40.2)
Bilateral 13 (15.1) 37 (13.1) 14 (12.8) 36 (13.9)
White matter change, n (%)
Severe 44 (51.2) 141 (50.0) 56 (51.4) 129 (49.8)
Mild 42 (48.8) 141 (50.0) 53 (48.6) 130 (50.2)
Dysfunction at admission, n (%)
Motor dysfunction 48 (55.8) 152 (53.9) 55 (50.5) 145 (56.0)
Sensory dysfunction 6 (7.0) 50 (17.7)* 17 (15.6) 39 (15.1)
Both motor and sensory dysfunction 29 (33.7) 42 (14.9)** 29 (26.6) 42 (16.2)
MCMQ score, mean ± SD
Confrontation 20.4 ± 2.4 20.1 ± 2.5 20.7 ± 2.5 20.0 ± 2.5*
Avoidance 14.3 ± 2.0 14.0 ± 1.6 14.2 ± 2.1 14.0 ± 1.5
Acceptance-resignation 9.8 ± 2.2 7.7 ± 1.7** 8.6 ± 2.4 8.0 ± 1.8*
SSRS score, mean ± SD
Subjective support 23.6 ± 2.2 23.8 ± 2.1 23.8 ± 2.1 23.7 ± 2.1
Objective support 9.1 ± 1.1 9.7 ± 1.0* 9.8 ± 0.9 9.7 ± 1.0
Degree of social utilization 5.8 ± 0.9 6.1 ± 1.1* 5.7 ± 0.8 6.1 ± 1.1**
BG basal ganglia, CR corona radiata, IC internal capsule, MCMQ Medical Coping Modes Questionnaire, n = number, PSF post-stroke fatigue,
SSRS Social Support Rating Scale, y years
* P B 0.05
** P B 0.01
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sensory dysfunction (P\ 0.05) and acceptance-resignation
(MCMQ; P\ 0.01), whereas PSD at 3 months was asso-
ciated with degree of social utilization (SSRS; P\ 0.01),
avoidance (MCMQ; P\ 0.01) and acceptance-resignation
(MCMQ; P\ 0.01). PSF at admission was also associated
with acceptance-resignation (MCMQ; P\ 0.01) and low
degree of social utilization (SSRS; P\ 0.01), whereas it
was related to BG, CR or IC infarction (P\ 0.05), the
confrontation (MCMQ; P\ 0.05) and acceptance-resig-
nation (MCMQ; P\ 0.01) styles, and low degree of social
utilization (SSRS; P\ 0.01) (Table 3).
Discussion
Here as we tracked likely predictors of PSD and PSF in
stroke patients to promote early identification and preven-
tion, both conditions changed constantly over time. Fatigue
and depression often accompanied occurrence after stroke.
Compared with previous studies in which PSF ranged from
36 to 77 % of stroke-afflicted subjects [24], the extent of
morbidity documented here represented by was lower, that
is, of 71 stroke patients we reviewed. PSF was present in
23.4 % at admission and 29.6 % at 3 months. However,
throughout this more than 2-year study, we observed that
PSD and PSF changed constantly as time passed.
Dopamine and serotonin are considered responsible for
fatigue in patients with Parkinson’s disease (PD) [25]. With
respect to localization of brain damage, basal ganglia,
corona radiate or internal capsule infarctions were the
independent factors associated with PSF 3 months after
stroke occurrence, whereas cerebellum infarction was not
susceptible to PSF. Previously, dopamine reward neurons
localized in the ventral tegmental area were found pro-
jecting into the ventral striatum [26]. Animal experiments
have shown that profuse serotonergic fibers from the
brainstem raphe nuclei project to the basal ganglia and the
cerebellum [27]. In accord, our results suggested that, PSF
was related to derangement of dopaminergic system sec-
ondary to strokes occurring in strategic areas. Elsewhere,
Table 3 Factors associated
with PSD and PSF as analyzed
using multiple logistic
regression
Variable B SE P value Exp (B)
PSD at admission
Both motor and sensory dysfunction at admission: yes 0.709 0.317 0.026 2.031
MCMQ score: acceptance-resignation, mean ± SD 0.385 0.075 0.001 1.470
Constant -4.945 0.680 0.000 0.007
PSD 3 months later
Sensory dysfunction at admission: yes -0.638 0.602 0.289 0.529
Both motor and sensory dysfunction at admission: yes 0.537 0.387 0.165 1.711
MCMQ: avoidance, mean ± SD 0.404 0.118 0.001 1.498
MCMQ: acceptance-resignation, mean ± SD 1.061 0.130 0.000 2.888
SSRS: degree of social utilization, mean ± SD -0.558 0.179 0.001 0.555
Constant -13.001 2.289 0.000 0.000
PSF at admission
Sensory dysfunction at admission: yes -0.611 0.511 0.232 0.543
Both motor and sensory dysfunction at admission: yes 0.321 0.340 0.345 1.379
MCMQ: acceptance-resignation, mean ± SD 0.624 0.087 0.000 1.866
SSRS: objective support, mean ± SD 0.169 0.144 0.238 1.185
SSRS: degree of social utilization, mean ± SD -0.401 0.154 0.009 0.670
Constant -5.849 1.988 0.003 0.003
PSF 3 month later
Weekly working hours: 1–20 h -20.220 11,799.472 0.999 0.000
Lesion location: CR ? BG ? IC 0.634 0.260 0.015 1.885
Lesion location: cerebellum -1.060 0.773 0.170 0.346
MCMQ score: confrontation, mean ± SD 0.118 0.051 0.021 1.125
MCMQ score: acceptance-resignation, mean ± SD 0.214 0.061 0.000 1.239
SSRS score: degree of social utilization, mean ± SD -0.410 0.133 0.002 0.664
Constant -2.727 1.549 0.078 0.065
MCMQ Medical Coping Modes Questionnaire, PSD post-stroke depression, PSF post-stroke fatigue, SSRS
Social Support Rating Scale
274 J Neurol (2016) 263:269–276
123
pharmacological studies yielded a reduction in fatigue
following the administration of a dopamine agonist [28].
High, moderate and low concentrations of extracellular
dopamine induced euphoric, seeking and aversive states,
respectively. Still other findings identified circuit loops
involving the cerebral cortex, basal ganglia, thalamus,
epithalamus, and midbrain through which dopaminergic
activity affected motivation [29]. In that study, lack of
energy or motivation, boredom, adynamia and lassitude
were the main symptoms of fatigue after stroke. Overall, in
our hands, the relationship between PSF and lesion location
was not significant during the acute stage indicating that
the redistribution of neurotransmitters may take some time.
Moreover, there was no evidence that PSD was related to
lesion location, despite the correlation between PSF and
PSD. Quite possibly though, PSD is an emotional distur-
bance associated with social stress, premorbid personality
or disability caused by stroke. In support, our study con-
firmed that types of neurologic dysfunction, social support
and coping styles were closely associated with PSD. Since
neurologic dysfunction was not an independent factor
related to PSF, correct cognitive appraisal may be neces-
sary to determine the pathogenesis of PSF.
Although we recorded age, gender, extent of formal
education and stroke history as background factors for the
patients included here, no significant differences emerged,
either at admission or at 3 months later. Although patients
with 1–20 h weekly working time were not susceptible to
PSF, this feature was not an independent factor involved in
development of PSF as judged by multivariate analyses.
Social support is often found to protect against the effects
of stress, with most studies finding either a main effect or a
buffering effect [30]. In our study, a low degree of social
utilization as a cognitive appraisal variable was an inde-
pendent risk factor associated with PSD at 3 months and
PSF at both time points after stroke. So, regardless of how
much social support was present, patients were routinely
encouraged to seek and use those opportunities during the
stroke recovery period. In addition, coping styles were
associated with the ability to seek social support. Feifel
[20] pointed out that acceptance-resignation indicated that
the expression of negative affect, lack of focus, and gloomy
expectations about the future always induced longer illness.
Records of acceptance-resignation related to PSD and PSF
both at admission and at 3 months later revealed that these
patients focused on their limited power to influence the
course of illness and lost confidence for recovery. High
avoidance scores of PSD patients denoted less self-directed
life orientation and negative self-perception [20]. Avoid-
ance only associated PSD for individuals with subacute
stroke indicated that this style may be effective for
managing short-term threats, but for the long-term prob-
lem-solving activity was more effective [14]. Higher scores
for confrontation by PSF patients indicated the presence of
extroversion, negative self-perception, a view of their ill-
ness as serious, religiosity, concern about life direction, the
situational variables of fearing death, and positive expec-
tations about recovery and the future. So apart from
effective cognitive ability, a confrontational coping style
was more important for patients with stroke. The results of
this study have potentially important implications for
intervention. Possibly, a change in strategies for coping
with stroke would reverse HPA-axis dysfunction, thereby
avoiding the symptoms of emotional disturbances and the
related pathogenic effects. Finally, the presence of a sig-
nificant relationship between coping and cortisol has been
noted in other studies [31]. With strategies for a new
direction to predict and to treat PSD and PSF, and by
engendering a greater willingness on the part of post-stroke
patients to be participants in their own recovery, medical
practitioners might improve outcomes.
The main limitations of our study are the size of our
sample, the single medical center used as a source of
patients and the short time period of only 3 months.
Because this is the first study that combines the specific
attributes measured here, caution dictated applying these
limitations as a foundation before engaging in a larger,
longer investigation. Further, we excluded patients with
severe neurologic conditions, aphasia, and cognitive
impairment and those who lived alone. The patients who
dropped out of the study before 3 months were older and
had more severe neurologic dysfunction at admission,
suggesting that occurrence of emotional disturbances may
have been underestimated.
Conclusion
Basal ganglia, corona radiate or internal capsule infarction
were the independent factors associated with PSF 3 months
after stroke occurrence. The appearance of PSD was not
related to lesion location. Both motor and sensory dysfunc-
tion was independently associated with PSD at admission. A
low degree of social utilization was the independent factor
associated with PSD and PSF at 3 months after stroke.
Acceptance-resignation independently related to PSD and
PSF both at admission and 3 months after stroke. Avoidance
was the independent factor related to PSD at 3 months,
whereas confrontation was the independent factor related to
PSF at 3 months after stroke onset.
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